Veterinary Contract Manufacturing Market Report 2026-2031, By Service, Product, and Geo

Veterinary Contract Manufacturing & Research Market by Service (Discovery, API Development, Regulatory Affairs, Consulting, Packaging & Labeling), Product (API, Fill-Finish, Medical Devices), Animal Type (Companion, Livestock) - Global Forecast to 2031

USD 9.24 BN

MARKET SIZE, 2031

CAGR 7.7%

(2026-2031)

498

REPORT PAGES

585

MARKET TABLES

OVERVIEW

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The Veterinary Contract Manufacturing & Research market, valued at US$5.92 billion in 2025, stood at USD 6.38 billion in 2026 and is projected to advance at a resilient CAGR of 7.7% from 2026 to 2031, culminating in a forecasted valuation of USD 9.24 billion by the end of the period. The market growth is driven by rising outsourcing of drug development and manufacturing, growing demand for advanced veterinary therapeutics such as biologics and vaccines, and the rising need for specialized research, testing, and GMP-compliant production capabilities.

KEY TAKEAWAYS

By Region

The North American veterinary contract manufacturing & research market accounted for a share of 50.3% in 2025.
By Service

By service, the CDMO services segment is projected to register the highest CAGR of 8.1%.
By Product type

By product type, the medicines segment dominated the market with 80.0% share in 2025.
By Animal Type

By animal type, the companion animals segment is projected to grow at the fastest rate from 2026 to 2031.
By End User

By end user, the multinational animal-health companies segment led the market, with a share of 49.7% in 2025.
Competitive Landscape - CRO Key Players

Labcorp, Eurofins Scientific, and Charles River Laboratories were identified as some of the star players in the veterinary contract manufacturing & research market, given their extensive global reach and comprehensive service portfolios.
Competitive Landscape - CRO Startups

Veterinary Research Management, Löhlein & Wolf Vet Research, and Cebiphar, among others, have distinguished themselves among startups and SMEs due to their specialized veterinary expertise and focused service capabilities.
Competitive Landscape - CDMO Key Players

Fareva, Argenta Holdco Limited, Aenova Group, and Fareva were identified as some of the star players in the veterinary contract manufacturing & research market, given their large-scale manufacturing capacity, international operations, and broad contract development services.
Competitive Landscape - CDMO Startups

CZ Vaccines, Ab7 Group, and EirGen Pharma, among others, have distinguished themselves among startups and SMEs due to their niche vaccine and biologics capabilities and strong innovation-driven product pipelines.

The veterinary contract manufacturing & research market is witnessing steady growth, driven by the expanding development pipelines of animal health companies, rising demand for outsourced R&D and manufacturing, and increasing focus on advanced therapeutics for both companion and livestock animals. New developments such as AI-enabled drug discovery tools, automation in bioprocessing, wearable animal health monitoring technologies, and strategic collaborations between CDMOs, CROs, and veterinary pharmaceutical manufacturers are reshaping the industry landscape and accelerating innovation across the sector.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The impact on consumers’ businesses in the veterinary contract manufacturing & research market stems from rising animal health needs, increasing therapeutic complexity, and rapid technological advancement. Veterinary pharmaceutical, biotechnology, and vaccine companies are the primary users of outsourced development, manufacturing, and research services, relying on CDMOs and CROs for faster scale-up, specialized expertise, and regulatory compliance. The growing demand for efficient, data-driven R&D, along with pressure to reduce costs and accelerate product launches, is reshaping operational strategies across the animal health sector. These factors are driving a greater reliance on advanced outsourcing partners and integrated service platforms, which in turn influence overall market growth and competitiveness.

Veterinary Contract Manufacturing Research Market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers

Impact
Level

Growth in Animal Health Spending
Increasing Complexity of Veterinary Biologics

RESTRAINTS

Impact
Level

Limited Specialized Infrastructure
Long Approval Timelines & Regulatory Diversity Globally

OPPORTUNITIES

Impact
Level

Geographic Expansion into Emerging Markets
Digital CRO Services

CHALLENGES

Impact
Level

Difficulty in Clinical Trial Recruitment
Difficulty in Scaling Sterile / Biologics Capacity Quickly

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Growth in Animal Health Spending

Rising global spending on companion and livestock animal health is a major driver for the veterinary contract manufacturing & research market. As pet ownership increases and livestock producers seek better disease prevention and productivity solutions, demand for new drugs, vaccines, and diagnostics continues to rise. This growing market pushes animal health companies to expand their pipelines and rely more on outsourced development, manufacturing, and research services, fueling steady growth for CDMOs and CROs.

Restraint: Limited Specialized Infrastructure

A key restraint in the veterinary contract manufacturing & research market is the shortage of specialized facilities and advanced manufacturing infrastructure required for complex biologics, vaccines, and innovative therapies. Many regions lack GMP-compliant production sites, high-containment research capabilities, and skilled technical personnel, limiting the ability of companies to scale up development. This gap increases dependence on a small number of capable service providers and slows overall market expansion.

Opportunity: Geographic Expansion into Emerging Markets

Emerging markets offer significant growth opportunities as countries in Asia-Pacific, Latin America, and the Middle East increase investments in livestock health, disease control programs, and companion animal care. These regions have growing unmet needs, less crowded competitive landscapes, and are increasingly aligned with global standards. CDMOs and CROs can tap these markets by establishing local partnerships, expanding service footprints, and offering cost-effective development and manufacturing solutions.

Challenge: Difficulty in Clinical Trial Recruitment

Recruiting suitable animals for clinical studies remains a major challenge in veterinary drug development. Variability across species, limited access to qualified trial sites, and strict ethical guidelines often slow down enrolment. Additionally, securing participation from pet owners and livestock producers can be difficult due to compliance concerns and logistical barriers. These recruitment challenges extend study timelines, increase development costs, and create operational hurdles for CROs and animal health companies.

VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY	USE CASE DESCRIPTION	BENEFITS
	Provides end-to-end preclinical and clinical research services for veterinary drugs and biologics, including toxicology, safety studies, and regulatory-ready data packages	Ensures faster study execution, high-quality GLP/GCP compliance, and smooth regulatory submissions for global approvals
	Offers specialized analytical testing for veterinary pharmaceuticals, vaccines, and residue monitoring using advanced chemistry and microbiology platforms	Enhances product quality, accelerates batch release, and supports regulatory compliance through accurate, validated testing
	Conducts veterinary-focused preclinical studies, disease modeling, and safety/toxicology programs using well-characterized laboratory animal models	Improves predictability of therapeutic outcomes, reduces development risk, and supports faster IND/MAA filings
	Provides veterinary drug manufacturing, sterile fill-finish, and formulation development across small molecules and biologics	Enables scalable GMP manufacturing, reduces cost of internal infrastructure, and speeds up commercial supply readiness
	Delivers drug discovery, screening, and translational research tailored to companion and livestock therapeutics	Increases R&D efficiency, identifies high-value candidates sooner, and shortens early-stage development timelines

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The ecosystem of the veterinary contract manufacturing & research market consists of a diverse network of stakeholders that collectively support innovation, product development, and outsourced research in animal health. Core contributors include specialized CDMOs and CROs offering formulation, manufacturing, analytical testing, and clinical trial services for veterinary pharmaceuticals, biologics, and medical devices. These service providers work closely with animal health companies, veterinary biotech start-ups, and research institutions that rely on outsourcing to accelerate development and reduce internal costs. Technology partners—such as developers of AI, digital data, and automation platforms—also play a growing role by enhancing study design, data management, and operational efficiency. Together, this ecosystem enables faster, more efficient development and commercialization of advanced veterinary therapeutics and solutions.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Veterinary Contract Manufacturing & Research Market, By Service

As of 2025, CDMO services held the largest share of the veterinary contract manufacturing & research market because animal health companies increasingly rely on external partners for formulation, process development, and GMP-compliant manufacturing to reduce internal costs and accelerate product timelines. The growing complexity of veterinary biologics, vaccines, and specialty formulations requires advanced capabilities and infrastructure that many companies prefer to outsource rather than build in-house. As demand for scalable, high-quality production continues to rise, CDMOs remain essential partners, driving their strong market dominance.

Veterinary Contract Manufacturing & Research Market, By Product Type

In 2025, medicines dominated the Veterinary contract manufacturing & research market, because pharmaceutical products—such as therapeutics, vaccines, and biologics—represent the core focus of animal health companies and account for the majority of product development and commercialization activities. The rising prevalence of infectious and chronic diseases in both companion and livestock animals continues to drive strong demand for new and improved veterinary drugs. Additionally, the increasing complexity of formulations, biologics manufacturing, and regulatory requirements pushes companies to rely more heavily on specialized CDMOs and CROs for R&D, analytical testing, and GMP-compliant production.

Veterinary Contract Manufacturing & Research Market, By Animal Type

As of 2025, companion animals held the largest share of the Veterinary contract manufacturing & research market due to rising pet ownership, increased spending on advanced veterinary care, and the humanization of pets are driving strong demand for new therapeutics, vaccines, and specialty formulations for dogs and cats. Chronic and lifestyle-related conditions in pets are becoming increasingly common, prompting animal health companies to expand their research and development (R&D) pipelines and rely more heavily on outsourced development, testing, and manufacturing. As a result, CDMOs and CROs see higher project volumes and consistent demand from the companion animal segment, making it the dominant contributor to market share.

Veterinary Contract Manufacturing & Research Market, By End User

The multinational animal health companies segment is expected to dominate the Veterinary contract manufacturing & research market, because they manage large global portfolios, invest heavily in R&D, and require extensive outsourcing support to meet manufacturing, analytical, and regulatory needs. Their broad pipelines of vaccines, biologics, and therapeutics create consistent demand for CDMO and CRO partnerships to expand capacity, enhance efficiency, and accelerate time-to-market across multiple regions.

REGION

Asia Pacific to be fastest-growing region in global Veterinary contract manufacturing & research market during forecast period

The Asia Pacific veterinary contract manufacturing & research market is expected to register the highest CAGR during the forecast period, driven by expanding livestock populations, rising pet adoption, and increasing investments in animal health infrastructure across major countries, such as China, India, and South Korea. The growing demand for vaccines, biologics, and premium veterinary medicines is driving companies to outsource development and manufacturing to meet the rising volume and quality requirements. Supportive government initiatives, lower operational costs, and the rapid expansion of regional CDMOs and CROs with modern capabilities are further accelerating growth. Additionally, global animal health companies are strengthening their presence in Asia Pacific through partnerships and facility expansions, making it a rapidly evolving hub for veterinary outsourcing services.

Veterinary Contract Manufacturing Research Market Region

VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: COMPANY EVALUATION MATRIX

In the veterinary contract manufacturing & research market matrix, Labcorp (Star) leads with a strong market presence supported by its extensive service portfolio, global client network, and deep expertise in preclinical and clinical research for animal health. The company’s leadership is reinforced by its advanced study capabilities, large-scale operational infrastructure, and long-standing partnerships with leading veterinary pharmaceutical companies. Klifovet GmbH (Emerging Leader) is rapidly gaining visibility with its specialized focus on veterinary clinical trials, regulatory consulting, and product development support, which enhance reliability, compliance, and study efficiency for clients. While other established CROs and CDMOs continue to expand capabilities, Labcorp’s scale and Klifovet’s niche expertise position them prominently in the evolving veterinary outsourcing landscape.

Veterinary Contract Manufacturing Research Market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

Labcorp (US)
Eurofins Scientific (Luxembourg)
Charles River Laboratories (US)
knoell Germany GmbH (Germany)
Evotec (Germany)
Klifovet GmbH (Germany)
Clinglobal (US)
BioAgile Therapeutics Private Limited (India)
VETSPIN SRL (Italy)
Ridgeway Research Ltd. (UK)
Argenta Holdco Limited (UK)
Aenova Group (Germany)
Fareva (France)
Vetio (US)
TriRx Pharmaceutical Services (US)
Indian Immunologicals Ltd. (India)
Recipharm AB (Sweden)
LABIANA (Spain)
Syngene International Limited (India)
CZ Vaccines (Spain)

MARKET SCOPE

REPORT METRIC	DETAILS
Market Size, 2025 (Value)	USD 5.92 Billion
Market Forecast, 2031 (Value)	USD 9.24 Billion
Growth Rate	CAGR of 7.7% from 2026 to 2031
Years Considered	2024-2031
Base Year	2025
Forecast Period	2026-2031
Units Considered	Value (USD Billion), Volume (API [Metric Tons] and FDF [Thousand Units])
Report Coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered	By Service: CRO Services CDMO Services By Product Type: Medicines Medical Devices By Animal Type: Companion Animals Livestock Animals By End User: Multinational Animal-Health Companies Mid-sized/Specialty Animal-Health Firms Startups & Veterinary Biotech Firms
Regions Covered	North America, Europe, Asia Pacific, Latin America, Middle East & Africa

WHAT IS IN IT FOR YOU: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET REPORT CONTENT GUIDE

Veterinary Contract Manufacturing Research Market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST	CUSTOMIZATION DELIVERED	VALUE ADDS
Service Analysis	Comparison of key veterinary contract manufacturing & research services, including formulation, analytical testing, biologics manufacturing, and clinical trial support Highlighted capacity trends, technology adoption, and service differentiation across major providers	Enabled identification of outsourcing patterns, cost drivers, and quality expectations; supported decisions on vendor selection, capability expansion, and service alignment with evolving animal health needs
Company Information	Key players: Aenova Group, Labcorp, Argenta Holdco Limited, Eurofins Scientific, and Charles River Laboratories Provided top players’ capabilities, service portfolios, and competitive positioning in North America and Europe	Delivered insights on partnership models, pipeline support opportunities, and investment hotspots shaping biologics, vaccine development, and advanced veterinary therapeutics
Geographic Analysis	Provided detailed analysis on Rest of Asia Pacific for veterinary outsourcing demand Focused on country-level evaluation of manufacturing capacity, regulatory ease, and CDMO/CRO expansion potential	Supported regional strategy planning, helping identify high-growth Asia Pacific markets for service expansion, localization opportunities, and partnership development

RECENT DEVELOPMENTS

October 2025 : Aenova Group announced the addition of a new fill-and-finish line at its Latina site. The company stated that this expansion strengthens its ability to meet rising global demand for biologics manufacturing, especially for late-stage clinical and commercial production.
December 2024 : Clinglobal announced the launch of a new brand within the Group: Clinaxel. This brand reinforced Clinglobal’s dedication to delivering high-quality field clinical trials and regulatory services across North America, Europe, and Africa.
February 2024 : Argenta Holdco Limited announced that its EMA- and FDA-approved Dundee site expanded its capabilities with a new high-tech blister line, strengthening its labelling and packaging services, and enhancing overall packaging operations.

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE

PAGE NO

INTRODUCTION

EXECUTIVE SUMMARY

PREMIUM INSIGHTS

MARKET OVERVIEW

Navigate complex veterinary biologics and regulatory landscapes to unlock emerging market opportunities.

4.1

INTRODUCTION

4.2

MARKET DYNAMICS

4.2.1

DRIVERS

4.2.1.1

GROWTH IN ANIMAL HEALTH SPENDING

4.2.1.2

INCREASING COMPLEXITY OF VETERINARY BIOLOGICS

4.2.1.3

RISING REGULATORY REQUIREMENTS FOR GMP, BIOSECURITY, AND ENVIRONMENTAL COMPLIANCE

4.2.2

RESTRAINTS

4.2.2.1

LIMITED SPECIALIZED INFRASTRUCTURE

4.2.2.2

LONG APPROVAL TIMELINES & REGULATORY DIVERSITY GLOBALLY

4.2.3

OPPORTUNITIES

4.2.3.1

GEOGRAPHIC EXPANSION INTO EMERGING MARKETS

4.2.3.2

DIGITAL CRO SERVICES

4.2.4

CHALLENGES

4.2.4.1

CHALLENGES IN CLINICAL TRIAL RECRUITMENT

4.2.4.2

DIFFICULTY IN SCALING STERILE/BIOLOGICS CAPACITY QUICKLY

4.3

UNMET NEEDS & WHITE SPACES

4.3.1

UNMET NEEDS IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET

4.3.2

WHITE SPACE OPPORTUNITIES

4.4

INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES

4.4.1

INTERCONNECTED MARKETS

4.4.2

CROSS-SECTOR OPPORTUNITIES

4.5

STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

4.5.1

STRATEGIC MOVES BY TIER-1/2/3 PLAYERS IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET

INDUSTRY TRENDS

Navigate competitive challenges with strategic insights on pricing, supply chain, and industry disruptions.

5.1

PORTER’S FIVE FORCES ANALYSIS

5.1.1

THREAT OF NEW ENTRANTS

5.1.2

THREAT OF SUBSTITUTES

5.1.3

BARGAINING POWER OF SUPPLIERS

5.1.4

BARGAINING POWER OF BUYERS

5.1.5

INTENSITY OF COMPETITIVE RIVALRY

5.2

MACROECONOMIC INDICATORS

5.2.1

INTRODUCTION

5.2.2

GDP TRENDS & FORECAST

5.2.3

TRENDS IN GLOBAL HEALTHCARE INDUSTRY

5.2.4

TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY

5.3

SUPPLY CHAIN ANALYSIS

5.4

VALUE CHAIN ANALYSIS

5.5

ECOSYSTEM ANALYSIS

5.6

PRICING ANALYSIS

5.6.1

AVERAGE SELLING PRICE TREND OF API & FILL-FINISH PHARMACEUTICALS & BIOLOGICS, BY KEY PLAYER, 2023–2025

5.6.2

AVERAGE SELLING PRICE TREND OF API & FILL-FINISH PHARMACEUTICALS & BIOLOGICS, BY REGION, 2023–2025

5.6.2.1

AVERAGE SELLING PRICE TREND OF SMALL-MOLECULE PHARMACEUTICALS FOR API/DRUG SUBSTANCE MANUFACTURING, BY REGION, 2023−2025

5.6.2.2

AVERAGE SELLING PRICE TREND OF SMALL-MOLECULE PHARMACEUTICALS FOR FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY REGION, 2023−2025

5.6.2.3

AVERAGE SELLING PRICE TREND OF ANIMAL HEALTH BIOLOGICS & VACCINES FOR API/DRUG SUBSTANCE MANUFACTURING, BY REGION, 2023−2025

5.6.2.4

AVERAGE SELLING PRICE TREND OF ANIMAL HEALTH BIOLOGICS & VACCINES FOR FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY REGION, 2023−2025

5.7

KEY CONFERENCES & EVENTS, 2026–2027

5.8

TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES

5.9

INVESTMENT & FUNDING SCENARIO

5.10

SUCCESS STORIES & REAL-WORLD APPLICATIONS

5.10.1

END-TO-END CDMO SUPPORT FOR ANIMAL HEALTH LATERAL FLOW DIAGNOSTICS

5.10.2

END-TO-END CDMO SUPPORT FOR FIRST-IN-CLASS VETERINARY MONOCLONAL ANTIBODY (MAB)

5.10.3

END-TO-END BIOLOGICS OPTIMIZATION FOR CANINE ANTIBODY PROGRAMS

STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, AND DIGITAL & AI ADOPTION

Unlock competitive advantage by leveraging AI-driven innovations and strategic patent insights in veterinary technology.

6.1

TECHNOLOGY ANALYSIS

6.1.1

KEY EMERGING TECHNOLOGIES

6.1.1.1

HIGH-THROUGHPUT IN VITRO & IN VIVO SCREENING PLATFORMS

6.1.1.2

AI/ML PLATFORMS FOR DRUG DISCOVERY

6.1.2

COMPLEMENTARY TECHNOLOGIES

6.1.2.1

LABORATORY AUTOMATION, ROBOTICS, AND SMART QC SYSTEMS

6.1.2.2

STABILITY, COLD CHAIN, AND PACKAGING OPTIMIZATION TECHNOLOGIES

6.1.3

ADJACENT TECHNOLOGIES

6.1.3.1

DIGITAL THERAPEUTICS & SOFTWARE-AS-A-MEDICAL-DEVICE (SAMD)

6.1.3.2

PRECISION LIVESTOCK TECHNOLOGIES

6.2

TECHNOLOGY/PRODUCT ROADMAP

6.2.1

NEAR TERM (2025–2027)

6.2.2

MID TERM (2028–2030)

6.2.3

LONG TERM (2030+)

6.3

PATENT ANALYSIS

6.3.1

PATENT PUBLICATION TRENDS FOR VETERINARY PHARMACEUTICALS

6.3.2

JURISDICTION & TOP APPLICANT ANALYSIS

6.4

FUTURE APPLICATIONS

6.4.1

ADVANCED BIOLOGICS & VACCINE MANUFACTURING PLATFORMS

6.4.2

DIGITALIZED, DATA-RICH CLINICAL DEVELOPMENT USING AI, REMOTE MONITORING, AND REAL-WORLD DATA

6.4.3

GLOBALIZED, REGULATORY-READY DEVELOPMENT WITH HARMONIZED QUALITY & MANUFACTURING SYSTEMS

6.4.4

INNOVATIVE FORMULATION TECHNOLOGIES FOR LONG-ACTING, SPECIES-TAILORED, AND DIFFICULT-TO-DELIVER PRODUCTS

6.5

IMPACT OF AI/GENERATIVE AI ON VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET

6.5.1

INTRODUCTION

6.5.2

MARKET POTENTIAL IN VETERINARY CONTRACT MANUFACTURING & RESEARCH ECOSYSTEM

6.5.3

AI USE CASES

6.5.4

KEY COMPANIES IMPLEMENTING AI IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET

SUSTAINABILITY & REGULATORY LANDSCAPE

Navigate global sustainability regulations with insights on eco-friendly materials and compliance standards.

7.1

REGIONAL REGULATIONS & COMPLIANCE

7.1.1

REGULATORY ANALYSIS

7.1.2

REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

7.1.3

INDUSTRY STANDARDS

7.2

SUSTAINABILITY INITIATIVES

7.2.1

RECYCLED AND ECO-FRIENDLY MATERIALS FOR VETERINARY PRODUCTS

7.2.2

SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES

7.2.3

CERTIFICATIONS, LABELING, AND ECO-STANDARDS

CUSTOMER LANDSCAPE & BUYER BEHAVIOR

Discover how key stakeholders shape buying decisions and uncover unmet needs across industries.

104

8.1

KEY STAKEHOLDERS & BUYING CRITERIA

8.1.1

KEY STAKEHOLDERS IN BUYING PROCESS

8.1.2

BUYING CRITERIA

8.2

CUSTOMER LANDSCAPE & BUYER BEHAVIOR

8.2.1

DECISION-MAKING PROCESS

8.2.2

ADOPTION BARRIERS & INTERNAL CHALLENGES

8.2.3

UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES

8.2.4

MARKET PROFITABILITY

VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 16 Data Tables

109

9.1

INTRODUCTION

9.2

CRO SERVICES

9.2.1

DISCOVERY & PRE-CLINICAL STUDIES

9.2.1.1

GROWING USE OF DISCOVERY & PRE-CLINICAL STUDIES TO ACCELERATE VETERINARY DRUG PIPELINE INITIATION

9.2.2

VETERINARY CLINICAL TRIALS

9.2.2.1

GROWING DEPENDENCE ON VETERINARY CLINICAL TRIALS TO VALIDATE SAFETY AND EFFICACY FOR REGULATORY APPROVALS TO BOOST MARKET

9.2.3

ANALYTICAL & BIOANALYTICAL SERVICES AND QUALITY ASSURANCE

9.2.3.1

RISING ADOPTION OF ANALYTICAL & BIOANALYTICAL SERVICES TO ENSURE HIGH-QUALITY, COMPLIANT VETERINARY PRODUCTS TO FUEL GROWTH

9.2.4

REGULATORY AFFAIRS & CONSULTING

9.2.4.1

INCREASING NEED FOR REGULATORY AFFAIRS & CONSULTING TO NAVIGATE COMPLEX GLOBAL VETERINARY APPROVAL PATHWAYS TO SUPPORT GROWTH

9.3

CDMO SERVICES

9.3.1

PROCESS API & FORMULATION DEVELOPMENT

9.3.1.1

GROWING FOCUS ON PROCESS API & FORMULATION DEVELOPMENT TO OPTIMIZE VETERINARY PRODUCT PERFORMANCE TO DRIVE GROWTH

9.3.2

MANUFACTURING

9.3.2.1

INCREASING OUTSOURCING OF MANUFACTURING TO SCALE PRODUCTION OF VETERINARY DRUGS AND BIOLOGICS

9.3.3

PACKAGING & LABELING

9.3.3.1

RISING DEPENDENCE ON PACKAGING & LABELING SERVICES TO ENSURE REGULATORY-COMPLIANT PRODUCT DELIVERY TO PROPEL MARKET

9.3.4

QUALITY/STABILITY & POST-MARKET SUPPORT

9.3.4.1

EXPANDING USE OF QUALITY, STABILITY, AND POST-MARKET SUPPORT TO MAINTAIN LIFECYCLE PRODUCT COMPLIANCE TO BOOST MARKET

VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million and Tons | 23 Data Tables

134

10.1

INTRODUCTION

10.2

MEDICINES

10.2.1

SMALL-MOLECULE PHARMACEUTICALS

10.2.1.1

API/DRUG SUBSTANCE MANUFACTURING

10.2.1.1.1

GROWING FOCUS ON API MANUFACTURING TO SUPPORT MARKET GROWTH

10.2.1.1.2

GLOBAL VOLUME ANALYSIS OF SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCE MANUFACTURING, BY REGION, 2024–2031 (METRIC TONS)

10.2.1.2

FILL-FINISH/DRUG PRODUCT MANUFACTURING

10.2.1.2.1

INCREASING DEMAND FOR FILL-FINISH OPERATIONS TO FUEL MARKET GROWTH

10.2.1.2.2

GLOBAL VOLUME ANALYSIS OF SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY REGION, 2024–2031 (TEN THOUSAND UNITS)

10.2.2

ANIMAL HEALTH BIOLOGICS & VACCINES

10.2.2.1

API/DRUG SUBSTANCE MANUFACTURING

10.2.2.1.1

RISING DEMAND FOR API/DRUG SUBSTANCE MANUFACTURING TO DRIVE GROWTH

10.2.2.1.2

GLOBAL VOLUME ANALYSIS OF ANIMAL HEALTH BIOLOGICS & VACCINES FOR API/DRUG SUBSTANCE MANUFACTURING, BY REGION, 2024–2031 (METRIC TONS)

10.2.2.2

FILL-FINISH/DRUG PRODUCT MANUFACTURING

10.2.2.2.1

RISING DEPENDENCE ON FILL-FINISH CAPABILITIES TO FUEL GROWTH

10.2.2.2.2

GLOBAL VOLUME ANALYSIS OF ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY REGION, 2024–2031 (THOUSAND UNITS)

10.2.3

MEDICATED FEED & SUPPLEMENTS

10.2.3.1

RISING USE OF MEDICATED FEED & SUPPLEMENTS TO ENHANCE LIVESTOCK HEALTH AND PRODUCTIVITY

10.3

MEDICAL DEVICES

10.3.1

DIAGNOSTICS

10.3.1.1

GROWING ADOPTION OF VETERINARY DIAGNOSTICS TO DRIVE MARKET GROWTH

10.3.2

MONITORING SYSTEMS

10.3.2.1

EXPANDING UTILIZATION OF MONITORING SYSTEMS TO IMPROVE REAL-TIME ANIMAL HEALTH MANAGEMENT TO FUEL GROWTH

10.3.3

IMPLANTS

10.3.3.1

INCREASING USE OF VETERINARY IMPLANTS TO SUPPORT LONG-TERM TREATMENT AND ORTHOPEDIC CARE TO DRIVE GROWTH

VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 14 Data Tables

160

11.1

INTRODUCTION

11.2

COMPANION ANIMALS

11.2.1

DOGS

11.2.1.1

HIGH ADOPTION RATES OF DOGS TO DRIVE MARKET GROWTH

11.2.2

CATS

11.2.2.1

RISING DISEASE PREVALENCE AMONG CATS TO DRIVE MARKET

11.2.3

HORSES

11.2.3.1

GROWING EQUINE POPULATION TO SUPPORT MARKET GROWTH

11.2.4

OTHER COMPANION ANIMALS

11.3

LIVESTOCK ANIMALS

11.3.1

CATTLE

11.3.1.1

GROWING CONSUMPTION OF MEAT TO DRIVE MARKET

11.3.2

SWINE

11.3.2.1

GROWING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET

11.3.3

POULTRY

11.3.3.1

INCREASING DEMAND FOR POULTRY MEAT TO CONTRIBUTE TO MARKET GROWTH

11.3.4

SHEEP & GOATS

11.3.4.1

GROWING GLOBAL DEMAND FOR WOOL TO DRIVE MARKET

11.3.5

OTHER LIVESTOCK ANIMALS

VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 4 Data Tables

180

12.1

INTRODUCTION

12.2

MULTINATIONAL ANIMAL HEALTH COMPANIES

12.2.1

INCREASED OUTSOURCING BY MULTINATIONAL ANIMAL HEALTH COMPANIES TO EXPAND GLOBAL PRODUCT DEVELOPMENT

12.3

MID-SIZED/SPECIALTY ANIMAL HEALTH FIRMS

12.3.1

RISING RELIANCE OF MID-SIZED & SPECIALTY ANIMAL HEALTH FIRMS ON CDMO/CRO PARTNERS TO BOOST PIPELINES

12.4

START-UPS & VETERINARY BIOTECH FIRMS

12.4.1

GROWING ENGAGEMENT OF START-UPS & VETERINARY BIOTECH FIRMS TO ACCESS ADVANCED DEVELOPMENT CAPABILITIES

VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY REGION

Comprehensive coverage of 10 Regions with country-level deep-dive of 21 Countries | 419 Data Tables.

187

13.1

INTRODUCTION

13.2

NORTH AMERICA

13.2.1

MACROECONOMIC OUTLOOK FOR NORTH AMERICA

13.2.2

NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031

13.2.3

NORTH AMERICA: VALUE ANALYSIS, 2024–2031

13.2.4

13.2.4.1

RISING PET POPULATION TO DRIVE DEMAND

13.2.5

CANADA

13.2.5.1

RISING PET ADOPTION RATE TO DRIVE MARKET

13.3

EUROPE

13.3.1

MACROECONOMIC OUTLOOK FOR EUROPE

13.3.2

EUROPE: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031

13.3.3

EUROPE: VALUE ANALYSIS, 2024–2031

13.3.4

GERMANY

13.3.4.1

GERMANY TO DOMINATE EUROPEAN MARKET DURING FORECAST PERIOD

13.3.5

13.3.5.1

INCREASING PET OWNERSHIP TO DRIVE MARKET GROWTH

13.3.6

FRANCE

13.3.6.1

RISING CASES OF ZOONOTIC DISEASES TO DRIVE MARKET GROWTH

13.3.7

ITALY

13.3.7.1

GROWING LIVESTOCK POPULATION TO SUPPORT MARKET GROWTH

13.3.8

SPAIN

13.3.8.1

INCREASING ANIMAL HEALTHCARE EXPENDITURE TO DRIVE MARKET GROWTH

13.3.9

NETHERLANDS

13.3.9.1

INCREASING COMPANION ANIMAL POPULATION TO DRIVE MARKET GROWTH

13.3.10

REST OF EUROPE

13.4

ASIA PACIFIC

13.4.1

MACROECONOMIC OUTLOOK FOR ASIA PACIFIC

13.4.2

ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031

13.4.3

ASIA PACIFIC: VALUE ANALYSIS, 2024–2031

13.4.4

CHINA

13.4.4.1

CHINA TO DOMINATE APAC MARKET DURING FORECAST PERIOD

13.4.5

JAPAN

13.4.5.1

AGING PET POPULATION TO DRIVE MARKET

13.4.6

INDIA

13.4.6.1

RISING LIVESTOCK POPULATION TO BOOST MARKET GROWTH

13.4.7

AUSTRALIA

13.4.7.1

RISING LIVESTOCK ANIMAL POPULATION AND INCREASING PET OWNERSHIP TO SUPPORT MARKET GROWTH

13.4.8

SOUTH KOREA

13.4.8.1

INCREASING DEMAND FOR PREVENTIVE CARE AND AGING PET POPULATION TO DRIVE MARKET

13.4.9

THAILAND

13.4.9.1

INCREASING DEMAND FOR PREVENTIVE CARE AND AGING PET POPULATION TO DRIVE MARKET

13.4.10

NEW ZEALAND

13.4.10.1

HIGH BIOSECURITY STANDARDS TO DRIVE MARKET

13.4.11

REST OF ASIA PACIFIC

13.5

LATIN AMERICA

13.5.1

MACROECONOMIC OUTLOOK FOR LATIN AMERICA

13.5.2

LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031

13.5.3

LATIN AMERICA: VALUE ANALYSIS, 2024–2031

13.5.4

BRAZIL

13.5.4.1

BRAZIL TO DOMINATE LATAM MARKET DUE TO RAPIDLY INCREASING LIVESTOCK POPULATION

13.5.5

MEXICO

13.5.5.1

RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS TO CONTRIBUTE TO MARKET GROWTH

13.5.6

ARGENTINA

13.5.6.1

RISING LIVESTOCK POPULATION TO FUEL MARKET GROWTH

13.5.7

REST OF LATIN AMERICA

13.6

MIDDLE EAST & AFRICA

13.6.1

MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

13.6.2

MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031

13.6.3

MIDDLE EAST & AFRICA: VALUE ANALYSIS, 2024–2031

13.6.4

GCC COUNTRIES

13.6.4.1

KINGDOM OF SAUDI ARABIA (KSA)

13.6.4.1.1

TECHNOLOGICAL ADVANCEMENTS & GOVERNMENT INITIATIVES TO BOOST GROWTH

13.6.4.2

UNITED ARAB EMIRATES (UAE)

13.6.4.2.1

GOVERNMENT SUPPORT AND HIGH LIVESTOCK POPULATION TO FUEL UAE'S MARKET GROWTH

13.6.4.3

REST OF GCC COUNTRIES

13.6.5

REST OF MIDDLE EAST & AFRICA

COMPETITIVE LANDSCAPE

Discover market dominance shifts among key veterinary CROs and CDMOs, highlighting strategic growth opportunities.

352

14.1

OVERVIEW

14.2

KEY PLAYER STRATEGIES/RIGHT TO WIN

14.3

REVENUE ANALYSIS, 2021−2025

14.3.1

KEY VETERINARY CONTRACT RESEARCH ORGANIZATIONS

14.3.2

KEY VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS

14.4

VETERINARY CRO MARKET SHARE ANALYSIS, 2025

14.4.1

GLOBAL MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025

14.4.2

RANKING OF KEY MARKET PLAYERS

14.4.3

US MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025

14.4.4

EUROPE MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025

14.5

VETERINARY CDMO MARKET SHARE ANALYSIS, 2025

14.5.1

GLOBAL MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025

14.5.2

RANKING OF KEY MARKET PLAYERS

14.5.3

US MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025

14.5.4

EUROPE MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025

14.6

COMPANY EVALUATION MATRIX: KEY VETERINARY CROS, 2025

14.6.1

STARS

14.6.2

EMERGING LEADERS

14.6.3

PERVASIVE PLAYERS

14.6.4

PARTICIPANTS

14.6.5

COMPANY FOOTPRINT: KEY VETERINARY CROS, 2025

14.6.5.1

COMPANY FOOTPRINT

14.6.5.2

REGION FOOTPRINT

14.6.5.3

SERVICE FOOTPRINT

14.6.5.4

PRODUCT TYPE FOOTPRINT

14.6.5.5

ANIMAL TYPE FOOTPRINT

14.7

COMPANY EVALUATION MATRIX: VETERINARY CRO STARTUPS/SMES, 2025

14.7.1

PROGRESSIVE COMPANIES

14.7.2

RESPONSIVE COMPANIES

14.7.3

DYNAMIC COMPANIES

14.7.4

STARTING BLOCKS

14.7.5

COMPETITIVE BENCHMARKING: VETERINARY CRO STARTUPS/SMES, 2025

14.7.5.1

DETAILED LIST OF KEY VETERINARY CRO STARTUPS/SMES

14.7.5.2

COMPETITIVE BENCHMARKING OF KEY VETERINARY CRO STARTUPS/SMES

14.8

COMPANY EVALUATION MATRIX: VETERINARY CDMOS, 2025

14.8.1

STARS

14.8.2

EMERGING LEADERS

14.8.3

PERVASIVE PLAYERS

14.8.4

PARTICIPANTS

14.8.5

COMPANY FOOTPRINT: KEY VETERINARY CDMOS, 2025

14.8.5.1

COMPANY FOOTPRINT

14.8.5.2

REGION FOOTPRINT

14.8.5.3

SERVICE FOOTPRINT

14.8.5.4

PRODUCT TYPE FOOTPRINT

14.8.5.5

ANIMAL TYPE FOOTPRINT

14.9

COMPANY EVALUATION MATRIX: VETERINARY CDMO STARTUPS/SMES, 2025

14.9.1

PROGRESSIVE COMPANIES

14.9.2

RESPONSIVE COMPANIES

14.9.3

DYNAMIC COMPANIES

14.9.4

STARTING BLOCKS

14.9.5

COMPETITIVE BENCHMARKING: VETERINARY CDMO STARTUPS/SMES, 2025

14.9.5.1

DETAILED LIST OF KEY VETERINARY CDMO STARTUPS/SMES

14.9.5.2

COMPETITIVE BENCHMARKING OF KEY VETERINARY CDMO STARTUPS/SMES

14.10

SERVICE COMPARATIVE ANALYSIS

14.11

COMPANY VALUATION & FINANCIAL METRICS

14.11.1

FINANCIAL METRICS

14.11.2

COMPANY VALUATION

14.12

COMPETITIVE SCENARIO

14.12.1

SERVICE LAUNCHES & APPROVALS

14.12.2

DEALS

14.12.3

EXPANSIONS

14.12.4

OTHER DEVELOPMENTS

COMPANY PROFILES

In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)

388

15.1

CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS

15.1.1

KEY PLAYERS

15.1.1.1

ARGENTA HOLDCO LIMITED

15.1.1.1.1

BUSINESS OVERVIEW

15.1.1.1.2

SERVICES OFFERED

15.1.1.1.3

RECENT DEVELOPMENTS

15.1.1.1.4

MNM VIEW

15.1.1.2

AENOVA GROUP

15.1.1.2.1

BUSINESS OVERVIEW

15.1.1.2.2

SERVICES OFFERED

15.1.1.2.3

RECENT DEVELOPMENTS

15.1.1.2.4

MNM VIEW

15.1.1.3

FAREVA SA

15.1.1.3.1

BUSINESS OVERVIEW

15.1.1.3.2

SERVICES OFFERED

15.1.1.3.3

MNM VIEW

15.1.1.4

VETIO

15.1.1.4.1

BUSINESS OVERVIEW

15.1.1.4.2

SERVICES OFFERED

15.1.1.4.3

MNM VIEW

15.1.1.5

TRIRX PHARMACEUTICAL SERVICES

15.1.1.5.1

BUSINESS OVERVIEW

15.1.1.5.2

SERVICES OFFERED

15.1.1.5.3

MNM VIEW

15.1.1.6

INDIAN IMMUNOLOGICALS LTD.

15.1.1.6.1

BUSINESS OVERVIEW

15.1.1.6.2

SERVICES OFFERED

15.1.1.7

RECIPHARM AB

15.1.1.7.1

BUSINESS OVERVIEW

15.1.1.7.2

SERVICES OFFERED

15.1.1.7.3

RECENT DEVELOPMENTS

15.1.1.8

LABIANA

15.1.1.8.1

BUSINESS OVERVIEW

15.1.1.8.2

SERVICES OFFERED

15.1.1.8.3

RECENT DEVELOPMENTS

15.1.1.9

SYNGENE INTERNATIONAL LIMITED

15.1.1.9.1

BUSINESS OVERVIEW

15.1.1.9.2

SERVICES OFFERED

15.1.1.9.3

RECENT DEVELOPMENTS

15.1.1.10

CZ VACCINES

15.1.1.10.1

BUSINESS OVERVIEW

15.1.1.10.2

SERVICES OFFERED

15.1.2

OTHER PLAYERS

15.2

CONTRACT RESEARCH ORGANIZATIONS

15.2.1

KEY PLAYERS

15.2.2

OTHER PLAYERS

RESEARCH METHODOLOGY

467

16.1

RESEARCH DATA

16.2

RESEARCH METHODOLOGY DESIGN

16.2.1

SECONDARY DATA

16.2.1.1

KEY DATA FROM SECONDARY SOURCES

16.2.2

PRIMARY DATA

16.2.2.1

KEY DATA FROM PRIMARY SOURCES

16.2.2.2

KEY INDUSTRY INSIGHTS

16.3

MARKET SIZE ESTIMATION

16.3.1

BOTTOM-UP APPROACH

16.4

MARKET BREAKDOWN & DATA TRIANGULATION

16.5

MARKET SHARE ESTIMATION

16.5.1

RESEARCH ASSUMPTIONS

16.5.2

GROWTH RATE ASSUMPTIONS

16.6

RISK ASSESSMENT

16.7

RESEARCH LIMITATIONS

16.7.1

METHODOLOGY-RELATED LIMITATIONS

16.7.2

SCOPE-RELATED LIMITATIONS

APPENDIX

484

17.1

DISCUSSION GUIDE

17.2

KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

17.3

CUSTOMIZATION OPTIONS

17.3.1

SERVICE ANALYSIS

17.3.2

Methodology

This research study extensively utilized both primary and secondary sources. It involved analyzing various factors that influence the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and the strategies employed by key players.

Secondary Research

This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary contract manufacturing & research market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments about both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

Primary Research

In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development, and operations managers, as well as presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary contract manufacturing & research market. Primary sources from the demand side include R&D scientists and researchers in animal health companies, veterinary clinicians, and veterinary biotech firms developing veterinary therapeutics and technologies.

A breakdown of the primary respondents is provided below:

Veterinary Contract Manufacturing & Research Market

Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

Note 2: Other designations include sales, marketing, and product/service managers.

Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the veterinary contract manufacturing & research market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

Data Triangulation

After arriving at the veterinary contract manufacturing & research market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and obtain precise statistics for all segments and subsegments.

Market Definition

The veterinary contract research organization (CRO) market comprises third-party service providers that support animal-health companies in the outsourced research and development of veterinary pharmaceuticals, biologics, vaccines, and related products. Veterinary CROs provide services across the product lifecycle, including discovery support, preclinical studies, target animal safety, clinical field trials, bioequivalence studies, regulatory consulting, and post-approval research, in compliance with veterinary regulatory standards. These services are primarily used by animal-health pharmaceutical companies, biotechnology firms, and vaccine developers to reduce development timelines, access specialized expertise, manage regulatory complexity, and optimize R&D costs without maintaining a complete in-house research infrastructure. The veterinary contract development and manufacturing organization (CDMO) market consists of third-party manufacturers that provide outsourced development, scale-up, and commercial manufacturing services for veterinary drugs, biologics, vaccines, and related products. Veterinary CDMOs support animal-health companies through process and formulation development, API and finished dosage form manufacturing, fill-finish operations, packaging and labeling, quality control, stability testing, and regulatory manufacturing support, operating in accordance with veterinary GMP and biologics regulations. These services enable animal-health companies to outsource capital-intensive manufacturing activities, increase production flexibility, manage capacity constraints, and accelerate market entry, particularly for complex formulations, sterile injectables, and veterinary vaccines.

Stakeholders

Animal-health pharmaceutical companies
Veterinary biotechnology companies
Veterinary biologics & vaccine developers
Veterinary contract development & manufacturing organizations (CDMOs)
Veterinary contract research organizations (CROs)
Preclinical & toxicology research laboratories (GLP & non-GLP)
Clinical trial management organizations for veterinary studies
Regulatory consulting firms specializing in VICH / EMA / FDA-CVM
Quality control & analytical testing laboratories (veterinary-focused)
Veterinary formulation & process development service providers
Packaging, filling, and labeling service providers for veterinary products
Animal research facilities & field trial centers
Veterinary academic research institutes
Livestock research institutions & herd-health trial networks
Raw material suppliers for veterinary APIs, excipients, and biologics components

Report Objectives

To define, describe, segment, and forecast the veterinary contract manufacturing & research market by service, product type, animal type, end user, and region
To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall veterinary contract manufacturing & research market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To forecast the size of the veterinary contract manufacturing & research market in five central regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
To profile the key players in the veterinary contract manufacturing & research market and comprehensively analyze their core competencies and market shares
To track and analyze competitive developments such as acquisitions, service launches, expansions, collaborations, agreements, and partnerships

Veterinary Contract Manufacturing & Research Market by Service (Discovery, API Development, Regulatory Affairs, Consulting, Packaging & Labeling), Product (API, Fill-Finish, Medical Devices), Animal Type (Companion, Livestock) - Global Forecast to 2031

OVERVIEW

KEY TAKEAWAYS

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

MARKET DYNAMICS

Driver: Growth in Animal Health Spending

Restraint: Limited Specialized Infrastructure

Opportunity: Geographic Expansion into Emerging Markets

Challenge: Difficulty in Clinical Trial Recruitment

VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

MARKET ECOSYSTEM

MARKET SEGMENTS

Veterinary Contract Manufacturing & Research Market, By Service

Veterinary Contract Manufacturing & Research Market, By Product Type

Veterinary Contract Manufacturing & Research Market, By Animal Type

Veterinary Contract Manufacturing & Research Market, By End User

REGION

Asia Pacific to be fastest-growing region in global Veterinary contract manufacturing & research market during forecast period

VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: COMPANY EVALUATION MATRIX

KEY MARKET PLAYERS

MARKET SCOPE

WHAT IS IN IT FOR YOU: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS

RECENT DEVELOPMENTS

Table of Contents

Methodology

Secondary Research

Primary Research

Market Size Estimation

Data Triangulation

Market Definition

Stakeholders

Report Objectives

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Personalize This Research

Let Us Help You

TESTIMONIALS

JAYANT RAJPUROHIT

SFI Health,

BEATRIZ DE LA CALLE

Qualicaps,

Bob Williams,

Bracco Diagnostics Inc.,

Cody Coonradt,

3M Health Information Systems,

Growth opportunities and latent adjacency in Veterinary Contract Manufacturing & Research Market